Traders Magazine
0 Shares
ComplyAdvantage, a global data technology company transforming financial crime detection, announced a new investment by Goldman Sachs Growth Equity (“Goldman Sachs”). The terms of the transaction were not disclosed.
The investment is an extension to the company’s oversubscribed Series C funding announced in July 2020. Goldman Sachs joins a growing list of the company’s world-class investors including the Ontario Teachers’ Pension Plan Board, Index Ventures, and Balderton Capital.
ComplyAdvantage will use this new investment to build on the rapid growth it has experienced to date and cement its position as a critical part of the value chain for companies managing evolving risks around anti-money laundering (AML), know your customer (KYC) processes, and broader financial crime.
Rockville s DrFirst lands $50M investment for product expansion, sharper focus on innovation bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
Amount, a company that provides technology to banks and financial institutions, has raised $99 million in a Series D funding round at a valuation of just over $1 billion. WestCap, a growth equity firm founded by ex-Airbnb and Blackstone CFO Laurence Tosi, led the round. Hanaco Ventures, Goldman Sachs, Invus Opportunities and Barclays Principal Investments […]
DrFirst Raises $50M in Equity Funding
DrFirst, a Rockville, Md.-based health technology company, raised $50m in equity funding.
Sixth Street Growth made the investment. Following Sixth Street’s previous $35m investment and another $50m from Goldman Sachs Growth, both in 2020, DrFirst’s investment total over the past year is now $135m. In conjuntion with the funding, Lee Mooney of Sixth Street has joined DrFirst’s Board of Directors.
The company intends to use the funds to continue to expand operations and its business reach.
Led by James F. Chen, CEO and chairman, DrFirst makes e-prescription and telehealth-related software products for healthcare providers, payers and life science companies including medication management, care collaboration, medication adherence, and price transparency for prescriptions and medical procedures. The company’s solutions are used by nearly 300,000 healthcare professionals, including more than 100,000 prescribers, nearly half of the electr